ライフサイエンスコーパス: claim

1 estigates the theoretical foundation of this claim.

2 y extracted oils tested supported the health claim.

3 ce-like cone mosaics are congruent with this claim.

4 es of evidence are reviewed in support of my claim.

5 tical given the extraordinary nature of this claim.

6 is no experimental evidence supporting this claim.

7 sidered necessary to achieve the performance claim.

8 here is little evidence to substantiate this claim.

9 7 and 2016 were identified and linked to ADP claims.

10 d the evidence in support of their different claims.

11 tained from physician and pharmacist billing claims.

12 research makes it difficult to evaluate such claims.

13 vealing mostly higher amounts than the label claims.

14 We discuss why we disagree with these claims.

15 f a dozen 'early' grains cast doubt on these claims.

16 ion-drug fills and 0.54 for injury-insurance claims.

17 ation-based using 2010-2019 Medicare carrier claims.

18 es-Heart Failure registry linked to Medicare claims.

19 increasingly diverse fields, make just such claims.

20 codes, 7 days before and 3 days after part D claims.

21 (n=3614) linked to Medicare fee-for-service claims.

22 0.79-1.22), but noninferiority could not be claimed.

23 Tuberculosis (TB) claims 1.5 million lives per year.

24 ser cohort studies using five-state Medicaid claims (1999-2012) and Optum Clinformatics commercial cl

25 999-2012) and Optum Clinformatics commercial claims (2000-2016).

26 e instrumental variable analysis of Medicare claims (2012-2017) for 30,105 bariatric surgery patients

27 half that of studies based on administrative claims (21.4; 95%CI: 19.5-23.3) or modeling approaches (

28 increases in the total number of health care claims (25.61 vs. 28.99; P < 0.0001) and total annual he

29 ol analysis similarly indicated higher total claims (28.99 vs. 25.19; P < 0.0001) and health care cos

30 rter of the world population, yet it already claims ~60% of the global burden of heart disease.

31 Claims about Broca's area should be (re)cast in terms of

32 olicymakers and advocates make contradictory claims about the effects of providing military equipment

33 ogical approach used by the experimenter and claims about the nature of human behavior ought to be ke

34 We examined insurance claims among 133,439 opioid-naive adults undergoing surg

35 cumulation of Whi5, contradicting a previous claim and demonstrating the need for further models of c

36 Infants with birth hospitalization claims and >=24 months of continuous enrollment were ret

37 1.10, 1.22) times the total number of annual claims and an adjusted incident rate ratio 1.32 (95% con

38 e reanalysed the evidence underpinning those claims and apply more data to the question by using supe

39 Using national all-payer claims and data from electronic health records, we condu

40 data asset with de-identified administrative claims and electronic health record data, was used to id

41 data asset with de-identified administrative claims and electronic health records data.

42 entified in the Truven MarketScan Commercial Claims and Encounters database for the period 1 January

43 Medicare claims and IRIS(R) Registry data were used to calculate

44 ll data were linked to Medicare and Medicaid claims and pharmaceutical data.

45 Although claims and suits were infrequent given the large number

46 atients >=66 years of age linked to Medicare claims and treated with IV tPA at Get With The Guideline

47 stration, hospital admission, pharmaceutical claim, and socioeconomic status databases.

48 For each admission, we extracted facility, claims, and antibiotic data.

49 t findings on bioactive constituents, health claims, and health benefits of nuts and dried fruits and

50 seases, Tenth Revision codes, pharmaceutical claims, and laboratory results.

51 Administration review documents, healthcare claims, and national survey data.

52 ted Using Prospective Longitudinal Insurance Claims: Applying Techniques of Epidemiology) uses a stru

53 rders of cholesterol metabolism support this claim as do multiple lines of research that demonstrate

54 of dynamic ocean topography alone cannot be claimed as the surface absolute geostrophic current.

55 onale and overview of the FDG PET/CT Profile claims as well as its context, and to outline future nee

56 on Earth because the diseases they transmit claim at least a million human lives every year globally

57 icated outcomes versus outcomes derived from claims at 1 year (HiR) or 2 years (SURTAVI).

58 miums, state tort reforms, frequency of paid claims, average claim payment, physicians' claims histor

59 ed vancomycin or comparator, from commercial claims based in the United States.

60 ilty status was classified using a validated claims-based frailty index.

61 The claims-based index is a proxy for frailty and is likely

62 ve to SAVR was seen by using both trial- and claims-based outcomes (P(noninferiority)<0.001 for both)

63 ldren <=18 years of age at the time of first claim between 2007 and 2013.

64 ifeLink) that included persons who had filed claims between 2006 and 2015 in the United States.

65 ed reports of an HIV algorithm from Medicaid claims codes that have been compared with an HIV surveil

66 To support these claims, computer-predicted, prebiotic syntheses of sever

67 owever, olive oils can only support a health claim concerning the protection against oxidative stress

68 stomatopod crustacean Squilla mantis that he claimed correspond to insect mushroom bodies, today reco

69 ratio, 0.84 [95% CI, 0.65-1.09]; P=0.33) and claims data (hazard ratio, 0.86 [95% CI, 0.66-1.11]; P=0

70 % for TAVR and 12.5% for SAVR patients using claims data (hazard ratio, 1.02 [95% CI, 0.73-1.41]; P=0

71 asure is not directly observed, but Medicare claims data are available.

72 NFIP claims data are messy, but the size of the dataset provi

73 In this study based on claims data collected in South Korea, we aimed to explor

74 ce-in-differences study using administrative claims data covering 6.7% of US adults.

75 Claims data estimating rates of glaucoma medication adhe

76 The data set was merged with claims data for patients in accountable care organizatio

77 Using Medicare fee-for-service 5% claims data from 2007 to 2013, we analyzed treatment and

78 pective analysis of fee-for-service Medicare claims data from 761 acute care hospitals providing inpa

79 We analyzed claims data from a 20% national Medicare sample of patie

80 We analyzed claims data from a 20% national sample of Medicare benef

81 AND PARTICIPANTS: Retrospective analysis of claims data from a large US commercial insurer, represen

82 We performed a case-control study using claims data from all nonfederal emergency departments an

83 We analyzed claims data from Clinformatics DataMart Database for pat

84 s retrospective, inception cohort study used claims data from fee-for-service Medicare beneficiaries

85 Setting: claims data from Optum Labs Data Warehouse, a longitudin

86 We analyzed Medicare FFS claims data from surgeons who billed Medicare for 1 or m

87 was a retrospective study of administrative claims data from the MarketScan Commercial and Medicare

88 is retrospective study, using administrative claims data from the OptumLabs Data Warehouse, we identi

89 Using patient-level claims data from US commercial and Medicare payers, we i

90 We conducted a study using claims data in the Taiwan National Health Insurance Rese

91 re more closely concordant between trial and claims data than nonprocedural outcomes (eg, stroke, ble

92 We analyzed insurance claims data to better characterize histoplasmosis testin

93 study uses commercial and Medicare Advantage claims data to compare medication fills, outpatient visi

94 This study uses administrative claims data to describe trends in use of ICD-10-CM diagn

95 This study uses national pharmacy claims data to describes trends in prescriptions for HIV

96 Adding electronically-available patient claims data to facility models consistently improved ant

97 se-control study to administrative insurance claims data to identify cases with nAMD and risk-set sam

98 ment Advisory (MedPAC) has recommended using claims data wherever possible to measure clinical qualit

99 ross-sectional, drawn from administrative or claims data, or based on qualitative work in limited geo

100 and Results Using 2007 to 2014 US healthcare claims data, we ascertained a retrospective cohort of wo

101 gistry of Transplant Recipients and Medicare claims data, we studied 6780 HCV+ and 139 681 HCV- KT re

102 een 2009 and 2015 derived from 100% Medicare claims data.

103 lyses from medical records or administrative claims data.

104 and actionable cohorts using linked Medicare claims data.

105 cases and interventions were identified from claims data.

106 of HDV in the United States using real-world claims data.

107 l and febuxostat: a study using the Medicare claims data.

108 performance metric with the use of Medicare claims data.

109 ipant report, electronic health records, and claims data.

110 sing the Truven Health MarketScan Commercial Claims database (2001-2017), we performed a population-b

111 med using the MarketScan multistate Medicaid claims database (2013-2017), covering 12 million benefic

112 alysis of United States healthcare insurance claims database (July 2007-December 2014).

113 ationally representative American commercial claims database (Optum), which included 389,257 unique a

114 Patients were selected from an insurance claims database (PharMetrics LifeLink) that included per

115 In this large, commercial claims database analysis, no association was found betwe

116 were identified from a nationwide commercial claims database containing data from 2007 to 2015.

117 We reviewed a large insurance claims database for patients with migraine and matched c

118 ially insured patients in the IBM MarketScan claims database from 2011 to 2018.

119 Using a US administrative claims database with linked laboratory data, 34 569 new

120 We used a national private insurance claims database, Optum's de-identifed Clinformatics Data

121 on a large United States national commercial claims database, the IBM MarketScan, to identify patient

122 A de-identified longitudinal administrative claims database, the OptumLabs(R) Data Warehouse, was us

123 Setting: A large insurance claims database.

124 iate balance, might not be optimal for large claims-database studies with rich covariate information;

125 an international working group (RSV GEN) and claim databases.

126 rformed between 2003 and 2016 as reported in claims databases for all adults enrolled in fee-for-serv

127 sing the Truven Health MarketScan Commercial Claims databases from 2011-2014.

128 ge to health registries and health insurance claims databases, with follow-up until Jan 1, 2017.

129 f the IBM Watson Health MarketScan insurance claim dataset, which incorporates over 150 million uniqu

130 sectional study using a nationwide insurance claims dataset to study US adults aged 18 to 64 years.

131 baseline GLP-1RA were identified within 3 US claims datasets (2013-2018) and were 1:1 propensity scor

132 h Insurance Plan, expert opinion, medication claims datasets, and Ontario Drug Benefit Formulary medi

133 These results suggest that besides the claimed direct action on organoarsenicals, ArsH contribu

134 mes is presented in the context of the often-claimed direct electron transfer (DET) to glucose oxidas

135 By combining healthcare claims, electronic health records, familial whole-exome

136 s target prospective clients with misleading claims, expose patients to potentially risky stem cell-b

137 Government budgets, insurance claims, facility records, household surveys, and officia

138 erall, in the first 3 mo after their initial claim for mental illness, 44.85% of children who receive

139 Safety Authority (EFSA) authorised a health claim for olive oil (OO) containing at least 250 mg/Kg o

140 To support their claim for technical reasoning skills rather than imitati

141 imate age-specific mortality for an epidemic claiming for illustrative purposes 1 million US lives, w

142 We analyzed prescription drug claims for individuals prescribed PrEP in the Integrated

143 nducted of public and private administrative claims for Michigan residents insured by Medicare fee-fo

144 re is no evidence to support or refute these claims for nuts.

145 esting, especially male rural residents with claims for skin infections or endocarditis, commonly ass

146 g therapy, (3) glaucoma procedure, or (4) no claims for treatment.

147 signed to family physicians based on billing claim frequency, and then the association between colore

148 ld be considered diagnostic evidence about a claim from prior research.

149 100% Medicare FFS claims from 2013 to 2014 identified older adult inpatien

150 erence-in-difference analysis using Medicare claims from 2013-2017 to evaluate the association of BPC

151 Using Medicaid claims from 38 states from 2006 to 2014, we conducted a

152 e registry, as well as testing for CAD using claims from 90 days before to 90 days after index HF hos

153 multicenter analysis of commercial insurance claims from a statewide quality collaborative.

154 Claims from more than 10 million children were included.

155 ood vulnerability in the US using >2 million claims from the National Flood Insurance Program (NFIP).

156 aves acid-HMDS diffusion analysis (TAD), the claimed gold standard method.

157 Across disciplines, studies claim 'good genes' without measuring mating preferences,

158 Thus, contrary to the authors' claims, Hamilton's relatedness drives the evolution to a

159 Numerous claims have been made about the impacts of these protect

160 d claims, average claim payment, physicians' claims history, total malpractice payments, jury awards,

161 he Swedish neuroanatomist Bertil Hanstrom to claim homology in insects and crustaceans.

162 isease, etc.) were identified from physician claims, hospitalization, vital statistics, outpatient pr

163 the infection of millions of people and has claimed hundreds of thousands of lives.

164 to accept incoming information, because most claims in our environments are true.

165 We analyzed claims in the 3 months before to the 1 year after diagno

166 Claims in the lay literature suggest soaking nuts enhanc

167 stration experts and contradict many popular claims in the media.

168 orn planting and aflatoxin-related insurance claims in the United States, when controlling for temper

169 The number of claims increased by 187% for patients discharged from th

170 n Bolivia, where nearly half of all citizens claim indigenous origins, no specific guidelines have be

171 Neither claim is correct.

172 tailed hydrodynamic analysis supporting this claim is lacking.

173 An obvious challenge to this claim is the existence of adversarial images that fool D

174 Credibility of scientific claims is established with evidence for their replicabil

175 te-Risk Patients) to 100% Medicare inpatient claims, January 1, 2011, to December 31, 2016.

176 ed health products and CBD-associated health claims lacks a rigorous scientific foundation.

177 osed HCV patients using longitudinal medical claims linked to prescription data from approximately te

178 Supporting this claim, Lommatzsch demonstrated that omalizumab could saf

179 I, 99.32 to 100.00%), respectively, spanning claims made by each manufacturer.

180 S-CoV-2 has triggered a pandemic that is now claiming many lives.

181 ve been reported in 204 different countries, claiming more than 1 million lives worldwide.

182 Tuberculosis claims more human lives than any other bacterial infecti

183 disease (RHD) affects ~40 million people and claims nearly 300 000 lives each year.

184 ing challenge, due to the added value that a claim of origin could provide to the raw material itself

185 Phenols are responsible for the only health claim of virgin olive oil (VOO) recognized by the Europe

186 l models, this can result in unsubstantiated claims of a method's performance.

187 mation by abrasion, notwithstanding previous claims of added amorphous surface structures.

188 r findings with rats are contrary to classic claims of an impervious geometric module, they are consi

189 y can provide an unbiased method for testing claims of functional localization.

190 Here, we argue that published claims of opioid bias based on application of the operat

191 abase of de-identified administrative health claims of opioid-naive patients undergoing surgery from

192 include missing information on prescription claims of patients not included in the database, and for

193 ation [1] - an argument that refuted earlier claims of primate pheromones [3,4].

194 ive process is highly complex, and premature claims of successful heart regeneration have both fueled

195 ially concerns about the political power and claims on government resources of immigrants, African-Am

196 However, contradictory claims on the origin, magnitude, and consequence of this

197 The Profile provides two complementary claims on the precision of SUV measurements.

198 Sixty-three anesthesia-related claims or suits were filed by 50 plaintiffs.

199 r to SAVR when compared using both trial and claims (P(non)(inferiority)<0.001 for both).

200 g a nationwide health insurance database for claims paid during 2010-2017, we identified PWID by usin

201 avior performed only by animals, making this claim particularly newsworthy and interesting.

202 t reforms, frequency of paid claims, average claim payment, physicians' claims history, total malprac

203 lution are contradictory and enigmatic, with claims ranging from enthusiastic acceptance to outright

204 were applied to both Medicare and commercial claims, rates were calculated per 1000 enrollees, and tr

205 electronic health records or administrative claims records, is essential to successful recruitment i

206 sion criteria and make several other dubious claims regarding data processing, analysis, and interpre

207 l study, nor do we find evidence for broader claims regarding the effect of disgust and the existence

208 There were 5 claims related to general anesthesia including 4 deaths

209 ertainment of trial primary end points using claims reproduced both the magnitude and direction of tr

210 vague health benefits from disease-specific claims reserved for drugs.

211 garding the type of anesthesia in the closed claims, retrobulbar and peribulbar anesthesia were the m

212 A 5% claims sample was used for Poisson regression models to

213 Finally, I argue that optimality claims should be avoided, and that descriptive Bayesiani

214 Gilead et al. claim such diversity requires a multi-process theory, an

215 Deceptive claims surround us, embedded in fake news, advertisement

216 To claim that avoidance of animal products is required to p

217 They claim that BE is considered 'universal' and, thus, their

218 However, other studies claim that behavioral state moderates the relationship b

219 They also provide novel evidence for the claim that cerebral processing is limited by a constant

220 thetic PvD(1) to proteolytic degradation, we claim that conditions are now met to consider PDs drugga

221 sion with migration and find that the common claim that conformity can maintain between-group differe

222 Specifically, recent studies claim that cortical activity is generated intrinsically,

223 In this Opinion article, we discuss our claim that endogenous tumor exosomal PD-L1 and tumor-der

224 A recent claim that evening primrose flowers adaptively secrete n

225 device appears to morph into the substantive claim that humans are actually resource-rational.

226 Second, I review evidence challenging the claim that humans seek to minimize entropy.

227 behavior has widely been dismissed, with the claim that it violates the laws of thermodynamics.

228 Our results refute the longstanding claim that mastigonemes enhance flagellar thrust in C. r

229 However, while experimentalists are eager to claim that nongenetic modes of inheritance characterized

230 Our results support the claim that numerical discrimination in 3 vs 4 comparison

231 We claim that our construction scheme can give the complete

232 e need for more evidence to substantiate the claim that predation risk effects extend to prey populat

233 ical and an empirical challenge to Cushman's claim that rationalization is adaptive because it allows

234 They claim that reliance on narrow 'recycled' stimulus sets:

235 Osiurak and Reynaud (O&R) claim that research into the origin of cumulative techno

236 We claim that the potential impact of the sympagic plankton

237 I claim that these problems acquire their structure from t

238 It has long been claimed that certain configurations of facial movements

239 single RyR2 channels in vitro, reports have claimed that RyR2 inhibition by flecainide is not releva

240 ns of a recent study by DeSantis et al. that claimed that sabertooth cats and dire wolves did not com

241 ral studies using far-basal suppressor tones claimed that SFOAE components originate many octaves bas

242 It is claimed that this approach will alleviate site character

243 Although previous work claimed that this efflux pump extrudes the QS signal 3-o

244 along the PH(2)(-)-induced E2 pathway while claiming that "...no correlation between the thermodynam

245 of bibliometric indexes is opposed by those claiming that one's scientific impact cannot be reduced

246 in direct contradiction with a recent study claiming that the TMD does not interact with the cargo p

247 This research does not support claims that 'activating' nuts results in greater nutrien

248 en put forth: the hybrid barrel model, which claims that a lateral gate in BamA's beta-barrel can ser

249 incoming OMPs, and the passive model, which claims that a thinned membrane near the lateral gate of

250 This confirms previous claims that binding-induced changes in electron-transfer

251 nd advanced data analytic tools, have led to claims that common sense and clinical observation, rathe

252 aping of e-cigarettes is harmless, but these claims that e-cigarettes are safer and healthier are not

253 These findings support previous scholars' claims that journalistic norms of balance and objectivit

254 must be particularly vigilant about healing claims that lack solid foundational data.

255 Robock claims that our analysis fails to acknowledge that pan-t

256 In contrast to previous claims that PbgA functions as a cardiolipin transporter(

257 Cushman claims that post hoc rationalization of habitual behavio

258 lying science or differentiate the permitted claims that promise vague health benefits from disease-s

259 She claims that scene construction will lead to transformati

260 ization is mostly right on average, based on claims that the process must have emerged adaptively.

261 A prominent theory claims that the right temporoparietal junction (rTPJ) is

262 rutinized those findings and the theoretical claims that underlie them.

263 ce and arousal, contrasting with theoretical claims that valence and arousal are building blocks of s

264 Tomasello claims that we lack convincing evidence that nonhuman an

265 I discuss five possible objections to this claim: that genes can only survive if they confer benefi

266 the discovery of JNJ-53718678 which can now claim the leading position in clinical evaluation.

267 Tuberculosis (TB) continues to claim the lives of around 1.7 million people per year.

268 Both hypotheses claim the same qualitative mechanism-properly balanced e

269 navirus disease 2019 (COVID-19) pandemic has claimed the lives of over one million people worldwide.

270 peroxide" and the judgment bias based on the claimed theoretical specific energies.

271 nd point out the foundational issues that we claim this inability stems from.

272 Contrary to many of those claims, this paper uses observational multiplatform data

273 Using a large national database of insurance claims, this study focuses on variations in the type of

274 l market is saturated with technologies that claim to collect proficient, free-living sleep measureme

275 erovskite films under 1-sun illumination and claim to exclude heat-induced lattice expansion.

276 abeling and marketing of some products which claim to provide these benefits may be unsubstantiated.

277 ion in neuropil is contested and solutes are claimed to be transported by diffusion only.

278 lobal expansion of tree plantations is often claimed to have positive effects for mitigating global w

279 ons in various cortical areas, were recently claimed to include both Martinotti cells and non-Martino

280 the main components whose shedding has been claimed to represent the endothelial glycocalyx state of

281 The treatment claims to rejuvenate skin by improving facial lines, wri

282 Use of claims to substitute for adjudicated outcomes in traditi

283 of patients ages >= 65 with Medicare Part D claims undergoing surgery between January 1, 2009 and No

284 We evaluated these claims using Arabidopsis (Arabidopsis thaliana) knock-ou

285 these comorbidities and other patient-level claims variables to a facility model for risk-adjusting

286 primary data set, impute frailty status from claims variables, and conduct inference with those imput

287 n data set, model the frailty measure versus claims variables; in the primary data set, impute frailt

288 iting a pathological process that ultimately claims vulnerable cells.

289 han double inversion recovery, although this claim was not histopathologically validated.

290 To test this claim, we used a dissociation approach that allowed us t

291 Plaintiff claims were collected from the OMIC database from 2008 t

292 e 5 topical with sedation anesthesia-related claims were due to inadequate pain control (n = 2), ocul

293 Medicare administrative claims were used to evaluate mortality and stroke to 1 y

294 Medicare Part D claims were used to extract information on eye drop pres

295 , this therapeutic potency has not been well claimed when applied to human clinical trials.

296 osol bound forms, determinant for the health claim, which were also negatively affected by temperatur

297 are both criteria for workers' compensation claims, which are ultimately paid by industry.

298 However, each such claim will require extensive investigation to justify it

299 nt and outpatient procedures and constructed claims windows around them to define surgical episodes.

300 Procedure claims with laterality codes were used to determine pati